These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20146168)

  • 1. Effect of growth hormone (GH) on fasting and postprandial metabolism in GH deficiency.
    Trepp R; Stettler C; Diem P; Christ ER
    Exp Clin Endocrinol Diabetes; 2010 Oct; 118(9):596-601. PubMed ID: 20146168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial triglyceride profile after a standardized oral fat load is altered in growth hormone (GH)-deficient adult patients and is not improved after short-term GH replacement therapy.
    Perotti M; Caumo A; Brunani A; Cambiaghi N; Casati M; Scacchi M; Perra S; Rocco C; Mancia G; Grassi G; Cavagnini F; Pincelli AI
    Clin Endocrinol (Oxf); 2012 Nov; 77(5):721-7. PubMed ID: 22519803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
    Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
    Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
    Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
    Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of glucose and lipid metabolism and bone mineralization in patients with growth hormone deficiency with and without long-term growth hormone replacement.
    Roemmler J; Kuenkler M; Schneider HJ; Dieterle C; Schopohl J
    Metabolism; 2010 Mar; 59(3):350-8. PubMed ID: 19800640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
    Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M
    Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
    Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
    Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic abnormalities in growth hormone deficiency.
    Lanes R
    Pediatr Endocrinol Rev; 2004 Dec; 2(2):209-15. PubMed ID: 16429108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of cardiovascular disease in GH-deficient adults with hypopituitarism: a preliminary report.
    Bohdanowicz-Pawlak A; Szymczak J; Bladowska J; Bednarek-Tupikowska G; Bidzińska B; Milewicz A
    Med Sci Monit; 2006 Feb; 12(2):CR75-80. PubMed ID: 16449951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacement therapy and cardiovascular diseases.
    Boschetti M; Goglia U; Teti C; Esposito D; Giusti M; Minuto F; Ferone D
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):85-90. PubMed ID: 19020394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U; Wilton P; Jonsson P; ;
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
    Yuen KC; Dunger DB
    Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of GH on human skeletal muscle lipid metabolism in GH deficiency.
    Trepp R; Flück M; Stettler C; Boesch C; Ith M; Kreis R; Hoppeler H; Howald H; Schmid JP; Diem P; Christ ER
    Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1127-34. PubMed ID: 18413676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral inflammatory and fibrinolytic markers in adolescents with growth hormone deficiency: relation to postprandial dyslipidemia.
    Lanes R; Paoli M; Carrillo E; Villaroel O; Palacios A
    J Pediatr; 2004 Nov; 145(5):657-61. PubMed ID: 15520769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic consequences of GH deficiency.
    Jørgensen JO; Vestergaard E; Gormsen L; Jessen N; Nørrelund H; Christiansen JS; Møller N
    J Endocrinol Invest; 2005; 28(5 Suppl):47-51. PubMed ID: 16114276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects on insulin action in adult hypopituitarism of recombinant human GH therapy individually titrated for six months.
    McConnell EM; Atkinson AB; Ennis C; Hadden DR; McCance DR; Sheridan B; Bell PM
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5342-7. PubMed ID: 11701703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuation of hormone replacement therapy in young GH-treated hypopituitary women increases liver enzymes.
    Høst C; Christiansen JJ; Christiansen JS; Jorgensen JO; Gravholt CH
    Growth Horm IGF Res; 2010 Feb; 20(1):26-30. PubMed ID: 19660970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the skin characteristics in patients with severe GH deficiency and the effects of 6 months of GH replacement therapy: a randomized placebo controlled study.
    Tanriverdi F; Borlu M; Atmaca H; Koc CA; Unluhizarci K; Utas S; Kelestimur F
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):579-85. PubMed ID: 17054457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.